Oryn Therapeutics Opens Recruitment for Phase 1b Rheumatoid Arthritis Patients

June 25, 2021

Oryn Therapeutics has opened recruitment for rheumatoid arthritis patients for a Phase 1b clinical trial (“A Randomized, Double-blind, Vehicle Controlled, Repeat Dose Comparative Study in RA Patients Managed With DMARDs”). The details of the study can be found at:


A Phase 1a clinical trial study was successfully completed in 2020.